Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Medical Device
MGI Tech’s DNBSEQ-T1+ Gains CE IVDR Certification for EU Market Entry
June 23, 2025
Company
Deals
Jiangxi Rimag to Acquire 70% Stake in Guangzhou Gaomai for RMB 54 Million
June 23, 2025
Company
Drug
Simcere Pharma’s Quviviq Receives NMPA Approval for Insomnia Treatment
June 23, 2025
Company
Drug
Sanofi and Regeneron Win FDA Approval for Dupixent in Bullous Pemphigoid Treatment
June 23, 2025
Company
Drug
Zai Lab’s Partner argenx Secures EU Approval for Vygart in CIDP Treatment
June 23, 2025
Company
Deals
Harbour BioMed and Otsuka Pharma Collaborate Globally on BCMAxCD3 Bispecific T-cell Engager
June 23, 2025
Company
Drug
CanSino Biologics’ PCV13i Vaccine Gains NMPA Approval
June 23, 2025
Company
Drug
Zhongsheng Pharma’s RAY1225 Enters Phase III Trial for Obesity/Overweight Treatment
June 20, 2025
Company
Drug
Dizal’s Phase III Trial Completes Enrollment for Shuwozhe in EGFR Exon20ins NSCLC
June 20, 2025
Company
Drug
Shanghai Pharmaceuticals Receives Thai FDA Approval for Pregabalin Capsules
June 20, 2025
Company
Drug
Wantai Biological Launches Phase III Trial for VZV-7D Varicella Vaccine
June 20, 2025
Company
Drug
MSD Initiates IDeate-Prostate01 Phase III Trial of Ifinatamab Deruxtecan for mCRPC
June 20, 2025
1
2
…
326
327
328
329
330
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?